EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel

Nicollette L R Thornton iD, Warwick Black iD, Adrian Bognar iD, Daniel Dagge iD, Teresia Gitau iD, Bruce Hua iD, Gero Joks iD, Jarrad King iD, Andrew Lord iD, Elizabeth M Scott iD, Jelena Smit Callander iD, Serena Ting iD und 1 weitere

Asia-Pacific Psychiatry · 2023

DOI: 10.1111/appy.12550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Psychiatry, 2023. Verfasst von Nicollette L R Thornton und 12 weiteren Autor:innen. Beteiligte Einrichtung: Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Major Depressive Disorder, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen-Cilag Pty Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Major depressive disorder (MDD) can have severe impacts on function and quality of life. Up to one third of patients will have an inadequate response to their first line of treatment, with subsequent lines of therapy associated with lower remission rates and higher relapse rates. Recently esketamine has become available for Australian patients, and this agent provides an additional treatment option for those with MDD who have had an inadequate response to two or more antidepressant therapies during the current moderate to severe depressive episode. This paper provides an expert panel's practical recommendations and clinical guidance for establishing esketamine clinics in Australia.

Methods

An expert panel ( n = 11) comprising psychiatrists, mental health care nurses, pharmacists, and individuals with experience establishing esketamine clinics was convened in Sydney. The panel developed practical recommendations and clinical guidance, which were then further refined.

Results

Five key areas were identified: practical considerations for esketamine clinic set‐up, including multidisciplinary care considerations; patient selection; administering esketamine; adverse event management and long‐term follow‐up.

Conclusions

Guidance presented in this paper should assist Australian clinicians to set up an esketamine clinic, and provide practical advice on the infrastructure and clinical requirements for treatment of patients with this agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderDepressive Disorder, Treatment-ResistantHumansAntidepressive AgentsQuality of LifeAustraliaKetamine

Stichwörter der Autor:innen

Australiaclinical guidancedepressive disorderesketaminemajor

Substanzen

Antidepressive AgentsEsketamineKetamine

Autor:innen und Institutionen

  • Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Older Persons Mental Health Service, Rural and Remote Mental Health Services, South Australia, Australia.
  • Greenslopes Clinic, Queensland, Australia.
  • Greenslopes Private Hospital, Brisbane, Queensland, Australia.
  • Monarch Mental Health Group, New South Wales, Australia.
  • Perth Clinic, Western Australia, Australia.

ORCID-Profile: Nicollette L R Thornton, Warwick Black, Adrian Bognar, Daniel Dagge, Teresia Gitau, Bruce Hua, Gero Joks, Jarrad King, Andrew Lord, Elizabeth M Scott, Jelena Smit Callander, Serena Ting, Dennis Liu

Förderung

  • Janssen-Cilag Pty Ltd

Zitieren

APA

Thornton, N. L. R., Black, W., Bognar, A., Dagge, D., Gitau, T., Hua, B., Joks, G., King, J., Lord, A., Scott, E. M., Callander, J. S., Ting, S., & Liu, D. (2023). Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel. Asia-Pacific Psychiatry. https://doi.org/10.1111/appy.12550

Vancouver

Thornton NLR, Black W, Bognar A, Dagge D, Gitau T, Hua B, et al. Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel. Asia-Pacific Psychiatry. 2023. doi:10.1111/appy.12550

BibTeX
@article{Thornton2023,
  author = {Thornton, Nicollette L R and Black, Warwick and Bognar, Adrian and Dagge, Daniel and Gitau, Teresia and Hua, Bruce and Joks, Gero and King, Jarrad and Lord, Andrew and Scott, Elizabeth M and Callander, Jelena Smit and Ting, Serena and Liu, Dennis},
  title = {Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel},
  journal = {Asia-Pacific Psychiatry},
  year = {2023},
  doi = {10.1111/appy.12550}
}
Kostenlos starten →